Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.

Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.

UNLABELLED: Transient cognitive and behavioral stabilization of patients with Alzheimer's disease (AD) is the main goal of long-term acetylcholinesterase inhibitor (AChEI) therapy, but response to treatment is variable and, indeed, only some of the patients are stabilized. This is usually asse...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Nobili, F, Koulibaly, M, Vitali, P, Migneco, O, Mariani, G, Ebmeier, K, Pupi, A, Robert, P, Rodriguez, G, Darcourt, J
Formato:	Journal article
Idioma:	English
Publicado em:	2002

Registros relacionados

Automatic classification of SPECT images of Alzheimer's disease patients and control subjects
por: Stoeckel, J, et al.
Publicado em: (2004)

Using SPM as a diagnostic help with HMPAO-SPECT in Alzheimer's disease
por: Ebmeier, K, et al.
Publicado em: (2001)

Human brain acetylcholinesterase
por: Novales-Li, P
Publicado em: (1993)

Decreased CSF acetylcholinesterase activity in Alzheimer's disease.
por: Appleyard, M, et al.
Publicado em: (1983)

Effects of a single dose of the acetylcholinesterase inhibitor velnacrine on recognition memory and regional cerebral blood flow in Alzheimer's disease.
por: Ebmeier, K, et al.
Publicado em: (1992)

Astroglia up-regulate transcription and secretion of 'readthrough' acetylcholinesterase following oxidative stress.
por: Bond, C, et al.
Publicado em: (2006)

Astroglia up-regulate transcription and secretion of 'readthrough' acetylcholinesterase following oxidative stress
por: Bond, C, et al.
Publicado em: (2006)

A photopharmocology study with photoswitchable acetylcholinesterase inhibitors
por: Dhanaram Tangamanni
Publicado em: (2018)

Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease
por: Jean, L, et al.
Publicado em: (2007)

Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease.
por: Jean, L, et al.
Publicado em: (2007)

Statistical parametric mapping of (99m)Tc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease: normalizing to cerebellar tracer uptake.
por: Soonawala, D, et al.
Publicado em: (2002)

Impact of detergents on the activity of acetylcholinesterase and on the effectiveness of its inhibitors.
por: Zimmermann, M, et al.
Publicado em: (2009)

Molecular interaction of human acetylcholinesterase with trans-tephrostachin and derivatives for Alzheimer's disease
por: Pitchai, Arjun, et al.
Publicado em: (2020)

Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies.
por: Robb, SA, et al.
Publicado em: (2011)

Graphene quantum dots for ultrasensitive detection of acetylcholinesterase and its inhibitors
por: Li, Nan, et al.
Publicado em: (2016)

Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/Band ß-amyloid inhibitors for Alzheimer’s disease
por: Samina Khan Yusufzai, et al.
Publicado em: (2018)

Synthesis and evaluation of chromone-2-carboxamido-alkylamines as potent acetylcholinesterase inhibitors
por: Suwanhom, Paptawan, et al.
Publicado em: (2020)

Effectiveness of acetylcholinesterase inhibitors: diagnosis and severity as predictors of response in routine practice.
por: Van Der Putt, R, et al.
Publicado em: (2006)

Predicting the accuracy of a diagnosis of Alzheimer's disease with 99mTc HMPAO single photon emission computed tomography.
por: Dougall, N, et al.
Publicado em: (2004)

Acetylcholinesterase from the brain of Monopterus albus as detection of metal ions
por: S A M Khalidi, et al.
Publicado em: (2019)

Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia.
por: Barker, R, et al.
Publicado em: (2014)

Synthesis, characterization and crystal structure of new tetrahydro-β-carboline as acetylcholinesterase inhibitor
por: Mohamad Arshad, Ahmad Saifuddin, et al.
Publicado em: (2020)

Hierarchical And Fragment Based Virtual Screening Approaches In The Discovery Of Potent Acetylcholinesterase Inhibitor
por: Muhammad, Erma Fatiha
Publicado em: (2022)

2-Benzoyl-6-benzylidenecyclohexanone analogs as potent dual inhibitors of acetylcholinesterase and butyrylcholinesterase
por: Sze, Wei Leong, et al.
Publicado em: (2016)

Mood and cerebral perfusion revisited.
por: Ebmeier, K
Publicado em: (2000)

A review of antioxidant and anti-acetylcholinesterase activities of Centella asiatica (L.) Urb. for the treatment of Alzheimer’s disease
por: S., Abbas, et al.
Publicado em: (2021)

A review of antioxidant and anti-acetylcholinesterase activities of Centella asiatica (L.) Urb. for the treatment of Alzheimer’s disease
por: S., Abbas, et al.
Publicado em: (2021)

New class of acetylcholinesterase inhibitors from the stem bark of Knema laurina and their structural insights
por: Akhtar, Muhammad Nadim, et al.
Publicado em: (2011)

Probing the structure and dynamics of acetylcholinesterase inhibitors is the binding site using solid state NMR
por: Goodall, S, et al.
Publicado em: (2000)

Herpesviruses in brain and Alzheimer's disease.
por: Lin, W, et al.
Publicado em: (2002)

Alzheimer's brain changes
por: Cheah, Pike See, et al.
Publicado em: (2016)

The potential of acetylcholinesterase from monopterus albus brain for the detection of heavy metals and insecticides
por: Siti Aishah Muhammad Khalidi
Publicado em: (2020)

Purification and Characterization of Acetylcholinesterase from Clarias Batrachus and Oreochromis Mossambica Brain Tissues
por: Perumal, Natarajan
Publicado em: (2006)

Probing the structure of a potent acetylcholinesterase inhibitor in the binding site using solid state nuclear magnetic resonance.
por: Goodall, S, et al.
Publicado em: (2002)

Global cognitive impairment should be taken into account in SPECT-neuropsychology correlations: the example of verbal memory in very mild Alzheimer's disease.
por: Rodriguez, G, et al.
Publicado em: (2005)

The pharmacological treatment of Alzheimer's disease with cholinesterase inhibitors and memantine
por: Wilcock, G
Publicado em: (2007)

Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease.
por: Bradley, K, et al.
Publicado em: (2002)

Three-year follow-up of galantamine therapy for Alzheimer's disease: Efficacy and tolerability in open-label extension studies
por: Wilcock, G, et al.
Publicado em: (2002)

Hyperchaos in acetylcholinesterase enzyme systems
por: Ibrahim, Gamal, et al.
Publicado em: (1997)

Abnormal cerebral blood volume in regions of contused and normal appearing brain following traumatic brain injury using perfusion magnetic resonance imaging.
por: Garnett, MR, et al.
Publicado em: (2001)